ETF Managers Group, LLC Innoviva, Inc. Transaction History

ETF Managers Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $844,283 - $972,505	-61,943 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $832,513 - $1.09 Million	61,943 New	61,943 $894,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $854,813 - $1.05 Million	-61,943 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $726,591 - $913,659	61,943	61,943 $894,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.